Indianapolis-based pharmaceutical behemoth Eli Lilly has filed lawsuits against four compounders claiming that they sold unapproved products that contain tirzepatide, a key ingredient in the company’s weight-loss and diabetes drugs, including top-seller Mounjaro.The lawsuits against…
Continue Reading
Extended Wear CGM Innovation Redefines Diabetes Management
Dexcom has reached a significant milestone with FDA clearance for its G7 15-Day continuous glucose monitoring system for adults 18 and older. This next-generation device extends wear time…
Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it secured $100 million in Series C funding. Alpha Wave Ventures led the round with participation from existing investors AXA IM…
Continue Reading
Podimetrics, a company that helps patients with diabetes to prevent serious complications, is teaming up with HealthMed, an employee health and wellness platform.HealthMed aims to integrate Podimetrics’ SmartMat technology into its portfolio of benefits…
Continue Reading
What You Should Know:
– Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes…
Continue Reading
Artificial intelligence (AI) tools to support clinicians in providing patient-centered care can contribute to patient empowerment and care efficiency. We aimed to draft potential AI tools for tailored patient support corresponding to patients’ needs…
Continue Reading
FTC’s Landmark Antitrust Investigation Suspended
The Federal Trade Commission’s groundbreaking antitrust case against the nation’s three largest pharmacy benefit managers has been placed on hold following President Donald Trump’s controversial dismissal of two Democratic commissioners….
Comprehensive Remote Health Management
Teladoc Health has expanded its virtual care offerings with a new Cardiometabolic Health Program designed to address the growing challenges of diabetes, hypertension, and obesity. This innovative program combines remote health…
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes. G7 15 Day,…
Continue Reading
Metabolic syndrome is leading to an increased risk of diabetes and cardiovascular disease. Our study developed a model using retinal image data from fundus photographs taken during comprehensive health check-ups to classify metabolic syndrome….
Continue Reading
